Retatrutide · 20 mg
Freedom Diagnostics · 25 August 2026
Lot RT260720-123 · Accession 2608190910
Supplier: Peptidos Nueva Generacion. Current-stock batch match is unconfirmed.
PepVisionLabs£67.00
20 mg · For research use only
Online ordering opens soon. Contact us for product enquiries.
Retatrutide is part of the PepVision Labs research collection.
Contact our team for the lot details and applicable supplier documentation. No medical, diagnostic or personal-use advice is provided.
Supplier reports are available below. Check the sample and lot details; applicability to your stock batch must be confirmed.
Freedom Diagnostics · 25 August 2026
Lot RT260720-123 · Accession 2608190910
Supplier: Peptidos Nueva Generacion. Current-stock batch match is unconfirmed.
BTLabs · 28 April 2026
Lot RET020-012604A · Report BTL26281-02
Supplier: Veratides LLC. Measured content 22.6 mg (112.9%) exceeds the report’s stated 90–110% specification. Current-stock batch match is unconfirmed.
BTLabs · 29 April 2026
Lot RET020-012604A · Report BTL26281-28
Supplier: Veratides LLC. Endotoxin test for the identified sample only; it does not establish suitability for human use or certify another lot.
Compound background, research context and source references.
Explore this peptideEstimate containers needed from your study's amount, frequency and duration.
Enter your study values to calculate.
Arithmetic only. No allowance for stability, handling losses or variable study schedules. Quantity can be applied when ordering is available.
For laboratory research only. Not for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. Product images illustrate PepVision branding; supplied packaging may differ.